ScImage develops integrated PACS/RIS platform

Clint vanSonnenberg | | Health Imaging | Practice Management
ScImage has released its PicomEnterprise PACS platform, which integrates many RIS functions into a single PACS model.

The PicomEnterprise platform manages scheduling and modality worklists, processes tech notes and ER discrepancies, delivers a reading platform to the physician and allows customer-configuration of exam data, according to ScImage. The unified implementation model eliminates many duplicate front-end HIS and back-end EMR interface costs associated with RIS/PACS, the company said.

Los Altos, Calif.-based ScImage develops medical imaging, workflow and EMR management products and is marketing PicomEnterprise to radiology and all other clinical imaging departments.

Clint vanSonnenberg

Related Content

Clinicians want AI to show its work
Multidose contrast injectors could increase waste in some radiology departments
Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.